Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 9/20 | 0.55 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.52 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5757757 | 0.88 | ALDH1A1 (0.53) | SIGMAR1MEN1KMT2ASLC6A3 | |
| SCHEMBL6009479 | 0.88 | ALDH1A1 (0.53) | SIGMAR1MEN1KMT2ASLC6A3 | |
| Hydrochloric Acid SCHEMBL5756120 | 0.86 | ALDH1A1 (0.51) | SIGMAR1MEN1KMT2ASLC6A3 | |
| SCHEMBL28316666 | 0.86 | ALDH1A1 (0.54) | LTA4HSIGMAR1MEN1KMT2ASLC6A3 | |
| SCHEMBL9796769 | 0.86 | ALDH1A1 (0.54) | LTA4HSIGMAR1MEN1KMT2ASLC6A3 | |
| Hydrochloric Acid SCHEMBL5757965 | 0.84 | ALDH1A1 (0.53) | SIGMAR1MEN1KMT2ASLC6A3 | |
| SCHEMBL6980055 | 0.82 | GRIN2D (0.56) | LTA4HHRH3SLC6A3 | |
| Oxalic Acid SCHEMBL27277928 | 0.81 | KMT2A (0.52) | MEN1KMT2A | |
| SCHEMBL4731648 | 0.78 | MEN1 (0.55) | HRH3MEN1KMT2ASLC6A3 | |
| SCHEMBL10672928 | 0.78 | HRH3 (0.50) | HRH3SIGMAR1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1294690-A2 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Bristol-Myers Squibb Pharma Company (US) | 2003-03-26 | — | — | EP | disclosed |
| EP-1158980-A4 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARM CO (US) | 2002-04-03 | — | — | EP | disclosed |
| WO-2001098270-A2 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) | 2001-12-27 | — | — | WO | disclosed |
| EP-1158980-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | Du Pont Pharmaceuticals Company (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000035453-A1 | N-UREIDOALKYL-PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY | DU PONT PHARMACEUTICALS COMPANY (US) | 2000-06-22 | — | — | WO | disclosed |